首页 | 本学科首页   官方微博 | 高级检索  
检索        

以肺动脉高压为首发表现的先天性中枢性低通气综合征临床特征和基因分析
引用本文:胡燕,王春,郭予雄,王静,吴家兴,谭玉玉,郑贵浪,孙跃玉,潘微,李渝芬.以肺动脉高压为首发表现的先天性中枢性低通气综合征临床特征和基因分析[J].临床儿科杂志,2021,39(3):222-226.
作者姓名:胡燕  王春  郭予雄  王静  吴家兴  谭玉玉  郑贵浪  孙跃玉  潘微  李渝芬
作者单位:广东省人民医院 广东省医学科学院 1 . 儿科重症监护病房;2 .广东省心血管病研究所心儿科 (广东广州 510080)
基金项目:广东省登峰计划项目(No.KJ012019451);广东省科技计划项目(No.2019B020230003)。
摘    要:目的探讨先天性中枢性低通气综合征(CCHS)的临床和基因变异特征。方法分析1例首发表现为不明原因肺动脉高压的CCHS患儿的临床资料,并总结国内外文献中CCHS病例的临床特点、致病机制和基因变异情况。结果11月龄女婴,主要表现为浮肿、尿少、低血压、嗜睡、发绀、抽搐及颅内压增高。B型脑利钠肽、丙氨酸氨基转移酶升高,凝血酶原时间延长。颅脑磁共振示右侧额叶出血;超声心动图示中重度肺动脉高压。靶向捕获二代测序未发现可能的致病基因。采用Sanger法验证示患儿PHOX 2 B基因第3外显子存在多聚丙氨酸重复扩展变异,基因型为20/25。患儿入院后采用无创通气,睡眠时呼吸浅慢、微弱,伴血氧下降;血气分析提示二氧化碳潴留。随后改用夜间无创通气、降肺压药物治疗。复查肺动脉压力明显下降,生命体征稳定。随访至24月龄,夜间只需较低压力水平的无创通气,生长发育无异常。结论对于不明原因的肺动脉高压伴撤机困难患儿,需警惕CCHS。疑诊者应尽早针对CCHS相关基因进行靶向捕获二代测序及PHOX 2 B基因Sanger法验证。早期给予无创通气有望改善预后。

关 键 词:先天性中枢性低通气综合征    肺动脉高压    PHOX  2  B基因    儿童  

Clinical characteristics and genetic analysis of congenital central hypopnea syndrome with pulmonary hypertension as the first manifestation
HU Yan,WANG Chun,GUO Yuxiong,WANG Jing,WU Jiaxing,TAN Yuyu,ZHENG Guilang,SUN Yueyu,PAN Wei,LI Yufen.Clinical characteristics and genetic analysis of congenital central hypopnea syndrome with pulmonary hypertension as the first manifestation[J].The Journal of Clinical Pediatrics,2021,39(3):222-226.
Authors:HU Yan  WANG Chun  GUO Yuxiong  WANG Jing  WU Jiaxing  TAN Yuyu  ZHENG Guilang  SUN Yueyu  PAN Wei  LI Yufen
Institution:1 . Department of Pediatric Intensive Care Unit, 2 . Department of Pediatric Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, Guangdong, China
Abstract:Objective To analyze the clinical,laboratory examination and pathogenic genes of a case of congenital central hypopnea syndrome(CCHS).Methods The clinical manifestations,laboratory examination,echocardiography,treatment and follow-up of a child with CCHS with unexplained pulmonary hypertension were collected.The genes of the child and his parents were detected by targeted capture second generation sequencing technique.The reported pathogenic genes of CCHS were verified by Sanger method,and the clinical characteristics,pathogenic mechanism and gene mutation of CCHS were summarized and discussed in combination with domestic and foreign literature.Results The main manifestations of 11-monthold girls were edema,oliguria,hypotension,lethargy,cyanosis,convulsions;increased intracranial pressure,MRI suggested right frontal lobe hemorrhage;brain natriuretic peptide(BNP),glutamic pyruvic transaminase increased and prothrombin time prolonged;echocardiography showed moderate and severe pulmonary hypertension.No possible pathogenic genes were found in the second generation of targeted capture sequencing.After non-invasive ventilation,the breathing of the children was slow and weak during sleep,accompanied by a decrease in blood oxygen,and blood gas analysis showed carbon dioxide retention.The polyalanine repeat expansion mutation in exon 3 of PHOX 2 B was confirmed by Sanger method.Then the patients were treated with nocturnal non-invasive ventilation and antihypertensive drugs.The pulmonary artery pressure decreased significantly and the vital signs were stable.During the follow-up to 24 months old,only non-invasive ventilation with low pressure level was needed at night,and the growth and development was normal.Conclusion For children with unexplained pulmonary hypertension with difficulty in weaning,patients with suspected CCHS,should carry out the second generation of targeted capture sequencing of CCHS-related genes and Sanger verification of PHOX 2 B gene as soon as possible,which can avoid missed diagnosis of CCHS;and early non-invasive ventilation can improve the prognosis.
Keywords:congenital central hypopnea syndrome  pulmonary hypertension  PHOX 2 B gene  child
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《临床儿科杂志》浏览原始摘要信息
点击此处可从《临床儿科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号